Maverick Capital’s Fractyl Health GUTS Stock Holding History

Maverick Capital’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Sell	3,974,806 -273,686	-6%	-$252K	0.02%	84
2025 Q4	$9.35M	Hold	4,248,492	–	–	0.1%	55
2025 Q3	$6.76M	Hold	4,248,492	–	–	0.09%	65
2025 Q2	$6.88M	Hold	4,248,492	–	–	0.1%	56
2025 Q1	$5.06M	Hold	4,248,492	–	–	0.09%	83
2024 Q4	$8.75M	Hold	4,248,492	–	–	0.16%	54
2024 Q3	$10.7M	Sell	4,248,492 -6,176	-0.1%	-$20.2K	0.21%	50
2024 Q2	$18.2M	Hold	4,254,668	–	–	0.34%	48
2024 Q1	$31.5M	Buy	+4,254,668	New	+$35.8M	0.59%	45

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital's GUTS Position: Q1 2026 in Review

Maverick Capital reduced its Fractyl Health (GUTS) stake by 6.4% in Q1 2026, selling an estimated $252K and leaving 3,974,806 shares worth $1.82M. The position accounts for 0.02% of the portfolio, ranked #84.

Maverick Capital first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $31.5M in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Maverick Capital held 3,974,806 shares of Fractyl Health worth $1.82M as of Q1 2026.
Maverick Capital sold 273,686 Fractyl Health shares in Q1 2026, an estimated $252K.
Fractyl Health made up 0.02% of Maverick Capital's portfolio in Q1 2026, its #84 holding.
Maverick Capital first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
Maverick Capital's Fractyl Health position peaked at $31.5M in Q1 2024.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.